Growth finance for Series A companies: the 90-day install for PE-backed portfolio companies in emerging markets
The exact 90-day plan for standing up growth finance at Series A — the point where the founder can no longer be every function. Written for operating partners and portfolio CEOs inside private equity in emerging markets.
This edition of the Growth Broker playbook is written for operating partners and portfolio CEOs inside private equity operating in emerging markets. In this market, emerging-market buyers reward patient capital, currency-aware pricing, and a real local operating footprint, so the way you install growth finance has to be shaped to that reality from day one.
Series A is the moment growth finance stops being optional. The founder has to step out of some of the work, the plan requires a defensible growth number, and every quarter compounds toward the next raise.
Day 1 to 30: diagnosis and instrumentation. Name the constraint, write the ICP, wire CAC payback and gross margin into the board pack.
Day 31 to 60: first live cycle at 20% of planned volume. Founder still in every review. Kill criteria written and enforced.
Inside PE-backed portfolio companies, the binding constraint is almost always predictable execution against a hold-period thesis, and in emerging markets it is compounded by the fact that operating footprint and pricing fit, not brand awareness is what actually gates growth. Growth finance is only useful here when it is pointed at both constraints at once.
Day 61 to 90: ramp to full volume, hire the first dedicated operator, and hand off ops. Founder retains strategy and the weekly review.
By day 90 the metric is legible and the trajectory is defensible. This is what turns a Series A story into a Series B round.
Trap most Series A companies fall into: optimising for growth rate at any cost. It usually shows up around day 45 when the founder tries to hire ahead of the model.
The Series A version of growth finance looks small compared to what you will build at Series B. That is the point — it is a foundation, not a monument.
Concretely for PE-backed portfolio companies in emerging markets: the portfolio companies that install this hit the next value-creation milestone on schedule, and the teams that install this early own the category before Western vendors even show up. That is the reason it is worth installing growth finance deliberately for this market rather than importing a playbook designed for somewhere else.
Frequently asked questions
Growth Finance · PE-backed · emerging markets — answered
- Does growth finance work for PE-backed portfolio companies in emerging markets?
- Yes — provided it is pointed at predictable execution against a hold-period thesis and adapted to the fact that in emerging markets, emerging-market buyers reward patient capital, currency-aware pricing, and a real local operating footprint. The portfolio companies that install this hit the next value-creation milestone on schedule.
- Should we start growth finance before Series A?
- Yes if the founder has time; the Series A version is the same model at higher spend.
- How much of the round should fund growth finance?
- Meaningful — often 20–30% of the growth line — but only after diagnosis.
- When do we hire the first growth finance operator?
- Around day 60, once the model has run one full cycle with the founder.
- What Series A trap should we avoid?
- Optimising for growth rate at any cost — usually a premature senior hire.
- What is the emerging markets-specific pitfall when running growth finance for PE-backed?
- Importing a playbook that was built for another market. In emerging markets, emerging-market buyers reward patient capital, currency-aware pricing, and a real local operating footprint — the install has to reflect that.
Growth Broker editorial
Filed under growth finance · pe-backed · emerging markets